Os Therapies Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.75

-0.01 (-0.68%)

As of Nov 14, 2:36 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +4,271.8% upside

Low Target $26.16

Average Target $32.57

High Target $50.99

Current Price $0.75

Current
$0.75

Target
$32.57

$26.16 $32.57 avg $50.99

Scenario Analysis

Bear Case

$26.16

3,411.4%

Low target

Base Case

$32.57

+4,271.8%

Avg target

Bull Case

$50.99

+6,744.3%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$2.25

-66.9% from high

52-Week Low

$0.58

+28.5% from low

Target vs 52W High

$32.57

+1,347.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%